Current Report Filing (8-k)
May 17 2016 - 4:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 31, 2016
OCEAN BIO-CHEM,
INC
.
(Exact name of registrant as specified in charter)
Florida
|
|
0-11102
|
|
59-1564329
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
I.R.S. Employer Identification No.)
|
4041 S.W. 47 Avenue, Fort Lauderdale, Florida
33314
(Address of principal executive offices) (Zip
Code)
(954) 587-6280
Registrant’s telephone number, including
area code:
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On May 16, 2016 Ocean Bio-Chem, Inc. (the “Company”)
issued a press release announcing its financial results for the first quarter ended March 31, 2016. A copy of the press release
is furnished as Exhibit 99.1 to this Current Report.
The information furnished pursuant to Item 2.02 of this Current
Report, including the exhibits furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference
into future filings by the Company under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934,
as amended, unless the Company expressly sets forth in such future filing that such information is to be considered “filed”
or incorporated by reference therein.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
The Company is furnishing the following exhibit to this Current Report:
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release, dated May 16, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
OCEAN BIO-CHEM, INC.
|
|
|
|
|
|
Date: May 17, 2016
|
By:
|
/s/ Jeffrey S. Barocas
|
|
|
|
Jeffrey S. Barocas
|
|
|
|
Chief Financial Officer
|
|
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Sep 2023 to Sep 2024